Holdings
Deep Track Capital, LP
As of Sep 30, 2026, Deep Track Capital, LP reported 67 positions worth US$5.58B. Largest: Guardant Health, Inc., BioMarin Pharmaceutical Inc. and Immunovant, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Guardant Health, Inc. | 2.81M | US$500M | −588K | Sep 30, 2026 |
| BioMarin Pharmaceutical Inc. | 6.37M | US$382M | +3.07M | Sep 30, 2026 |
| Immunovant, Inc. | 9.16M | US$309M | −180K | Sep 30, 2026 |
| Tarsus Pharmaceuticals, Inc. | 3.81M | US$299M | +140K | Sep 30, 2026 |
| Veradermics, Incorporated | 1.9M | US$230M | −100K | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 7M | US$226M | +3M | Sep 30, 2026 |
| Vaxcyte, Inc. | 3.51M | US$200M | −787K | Sep 30, 2026 |
| Ocular Therapeutix, Inc. | 21.9M | US$168M | +2.25M | Sep 30, 2026 |
| United Therapeutics Corporation | 300K | US$163M | +176K | Sep 30, 2026 |
| Structure Therapeutics, Inc. | 5M | US$156M | new | Sep 30, 2026 |